Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Schneider Jerry A. Insider Profile
4 Followers
Schneider Jerry A., Director at Cognex, holds 5.00K shares in Kiromic Biopharma (Ticker: KRBP), holds 0.00 shares in Cognex (Ticker: CGNX). Most recently, Schneider Jerry A. Bought ― shares of Kiromic Biopharma on May 26, 2021 for an estimated value of 36.55K.
Profitable Transactions
4 out of 8 Profitable Transactions
Average Return
-18.60%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Schneider Jerry A. holds in companies
Most Profitable Insider Trade
The most profitable trade made by Schneider Jerry A.
Schneider Jerry A.'s Trading History
Cognex
Mar 22, 2021
Director
Informative Sell
$411.25K
$0.00
Kiromic Biopharma
May 26, 2021
Director
Informative Buy
$36.55K
$21.95K
List of latest transactions for each holding click on a transaction to see Schneider Jerry A.'s performance on stock
You May Also Like
Schneider Jerry A. insider profile FAQ
What is the percentage of profitable transactions made by Schneider Jerry A.?
The percentage of profitable transactions made by Schneider Jerry A. is 50%.
What is the average return per transaction made by Schneider Jerry A.?
The average return per transaction made by Schneider Jerry A. is -18.60%.
What stocks does Schneider Jerry A. hold?
Schneider Jerry A. holds: CGNX, KRBP stocks.
What was Schneider Jerry A.’s latest transaction?
Schneider Jerry A. latest transaction was an Informative Buy of $36.55K.
What was Schneider Jerry A.'s most profitable transaction?
Schneider Jerry A.’s most profitable transaction was an Informative Sell of CGNX stock on February 17, 2021. The return on the trade was 29.00%.
What is Schneider Jerry A.'s role in Cognex?
Schneider Jerry A.'s role in Cognex is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.